Filters

reset all
See more specimen types...

Other countries

Results: 1 to 10 of 10

Tests names and labsConditionsGenes, analytes, and microbesMethods

ABL1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoDysmorph Panel

Centogene AG - the Rare Disease Company
Germany
740728
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Connective Tissue Disorders Panel

Invitae
United States
19592
  • D Deletion/duplication analysis

Comprehensive Panel for Individualized Cancer Threatment

GeneKor MSA
Greece
1652
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing

ARUP Laboratories, Molecular Oncology ARUP Laboratories
United States
665
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HopeSeq HemeComplete

Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center
United States
112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ABL1 Single Gene

Fulgent Genetics
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hemato-oncology chromosomal microarray

Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center
United States
2393
  • D Deletion/duplication analysis
  • H Detection of homozygosity

BCR Single Gene

Fulgent Genetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clinical Exome

Fulgent Genetics
United States
51294672
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 10 of 10

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.